Preliminary evidence from in vivo studies and from epidemiologic reports suggest that obesity may affect BRCA penetrance through several mechanisms, including insulin resistance and insulin-like growth factor I (IGF-I) regulation. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.